Fospropofol in Monitored Anesthesia Care
Author Information
Author(s): Joseph V. Pergolizzi Jr., Gan Tong J., Plavin Stanford, Labhsetwar Sumedha, Taylor Robert
Primary Institution: Johns Hopkins University School of Medicine
Hypothesis
What is the role of fospropofol as a sedation agent in monitored anesthesia care?
Conclusion
Fospropofol is a promising new sedation agent for monitored anesthesia care, but further studies are needed to clarify its pharmacokinetic and pharmacodynamic properties.
Supporting Evidence
- Fospropofol demonstrated dose-dependent sedation with good success rates at doses of 6.5 mg/kg.
- Patients reported less pain at the injection site with fospropofol compared to propofol.
- Significant increases in sedation success were observed with higher doses of fospropofol.
Takeaway
Fospropofol is a new medicine that helps people sleep during minor surgeries, and it might be better than older medicines because it hurts less when injected.
Methodology
The study reviewed clinical trials evaluating the efficacy and safety of fospropofol in monitored anesthesia care.
Limitations
Limited clinical experience and the retraction of key pharmacokinetic studies hinder a thorough assessment of fospropofol.
Participant Demographics
The studies included adult patients undergoing outpatient procedures, with some studies reporting on geriatric patients.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website